We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMTC icon
251
Semtech
SMTC
$13B
$386K 0.17%
+8,554
New +$304K
INTC icon
252
Intel
INTC
$513B
$384K 0.17%
+17,153
New +$355K
EVER icon
253
EverQuote
EVER
$906M
$383K 0.17%
+15,849
New +$376K
ABT icon
254
Abbott
ABT
$187B
$381K 0.17%
+2,803
New +$370K
COP icon
255
ConocoPhillips
COP
$141B
$380K 0.17%
+4,240
New +$381K
INGR icon
256
Ingredion
INGR
$6.58B
$378K 0.16%
2,790
-1,126
-29% -$152K
UVV icon
257
Universal Corp
UVV
$1.27B
$378K 0.16%
+6,495
New +$374K
ATR icon
258
AptarGroup
ATR
$8.61B
$378K 0.16%
+2,417
New +$365K
UNP icon
259
Union Pacific
UNP
$174B
$378K 0.16%
1,642
-886
-35% -$197K
MTB icon
260
M&T Bank
MTB
$36.2B
$374K 0.16%
1,930
-7
-0.4% -$1.24K
AWI icon
261
Armstrong World Industries
AWI
$7.84B
$374K 0.16%
2,302
-1,448
-39% -$215K
LOPE icon
262
Grand Canyon Education
LOPE
$3.98B
$374K 0.16%
1,977
-1,559
-44% -$289K
UTHR icon
263
United Therapeutics
UTHR
$23.1B
$368K 0.16%
1,282
-225
-15% -$67.2K
TWLO icon
264
Twilio
TWLO
$36.6B
$368K 0.16%
+2,961
New +$315K
ACM icon
265
Aecom
ACM
$9.75B
$365K 0.16%
+3,237
New +$336K
PM icon
266
Philip Morris
PM
$295B
$365K 0.16%
2,002
-341
-15% -$58.6K
PENN icon
267
PENN Entertainment
PENN
$2.71B
$361K 0.16%
+20,224
New +$317K
SKY icon
268
Champion Homes
SKY
$5.14B
$361K 0.16%
+5,761
New +$448K
ARWR icon
269
Arrowhead Research
ARWR
$12.4B
$359K 0.16%
+22,712
New +$326K
BLFS icon
270
BioLife Solutions
BLFS
$1.7B
$356K 0.15%
+16,526
New +$372K
CNM icon
271
Core & Main
CNM
$8.71B
$351K 0.15%
+5,824
New +$312K
COST icon
272
Costco
COST
$420B
$351K 0.15%
355
-97
-21% -$96.4K
TER icon
273
Teradyne
TER
$59.3B
$348K 0.15%
3,866
-1,060
-22% -$84.7K
VIRT icon
274
Virtu Financial
VIRT
$4.93B
$346K 0.15%
+7,731
New +$312K
MARA icon
275
Marathon Digital Holdings
MARA
$3.9B
$345K 0.15%
+22,028
New +$315K
9 10
11
12 13

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.